Hypertension: history and development of established and novel treatments
- PMID: 29951800
- DOI: 10.1007/s00392-018-1299-y
Hypertension: history and development of established and novel treatments
Abstract
Background: This article summarizes the emerging field of hypertension over the last decades. It covers paradigm shifts on hypertension from an undefined cardiovascular condition to the most relevant cardiovascular modifiable risk factor and the developments of drug treatments and interventional treatments to improve cardiovascular outcomes.
Methods: We performed a selective literature research in PubMed on trials published in the past until 2018 without time restrictions and covered unpublished trials disclosed in ClinicalTrials.org.
Results: The development of treatments of hypertension is a success story covering many decades from the early attempts with drug treatments, development of tolerable and effective medications to interventional techniques involving renal denervation, AV fistulas, and autonomic devices. Novel guidelines define new definitions and treatment targets of hypertension, which are a matter of ongoing discussion.
Conclusion: Despite the development of tolerable and effective drugs, new treatments in the field of neuroendocrine modulation by drugs and devices are still under development trying to further improve treatment of patients with hypertension and to further reduce cardiovascular events in those individuals.
Keywords: Guideline overview; History of hypertension; Hypertension; Interventional treatment; Medical treatment.
Similar articles
-
Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?J Am Soc Hypertens. 2015 Feb;9(2):140-9. doi: 10.1016/j.jash.2014.12.002. Epub 2014 Dec 11. J Am Soc Hypertens. 2015. PMID: 25649995 Review.
-
Renal denervation in the treatment of resistant arterial hypertension.Wien Med Wochenschr. 2014 Dec;164(23-24):515-8. doi: 10.1007/s10354-014-0330-9. Epub 2014 Nov 14. Wien Med Wochenschr. 2014. PMID: 25394989
-
New approaches in the treatment of hypertension.Circ Res. 2015 Mar 13;116(6):1074-95. doi: 10.1161/CIRCRESAHA.116.303603. Circ Res. 2015. PMID: 25767291 Review.
-
Interventional cardiology: Indications for renal denervation: a balanced approach?Nat Rev Cardiol. 2013 Aug;10(8):434-6. doi: 10.1038/nrcardio.2013.85. Epub 2013 Jun 4. Nat Rev Cardiol. 2013. PMID: 23736520
-
Recent Developments and Controversies in the Treatment of Resistant Hypertension.Exp Clin Endocrinol Diabetes. 2016 Mar;124(3):178-86. doi: 10.1055/s-0042-100912. Epub 2016 Mar 23. Exp Clin Endocrinol Diabetes. 2016. PMID: 27008634 Review.
Cited by
-
Systematic review of renal denervation for the management of cardiac arrhythmias.Clin Res Cardiol. 2022 Sep;111(9):971-993. doi: 10.1007/s00392-021-01950-8. Epub 2021 Nov 8. Clin Res Cardiol. 2022. PMID: 34748053 Free PMC article.
-
The Association of Stage 1 Hypertension, Defined by the 2017 ACC/AHA Guidelines, With Cardiovascular Events Among Rural Women in Liaoning Province, China.Front Cardiovasc Med. 2021 Aug 12;8:710500. doi: 10.3389/fcvm.2021.710500. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34458337 Free PMC article.
-
Non-invasive evaluation of retinal vascular remodeling and hypertrophy in humans: intricate effect of ageing, blood pressure and glycaemia.Clin Res Cardiol. 2021 Jul;110(7):959-970. doi: 10.1007/s00392-020-01680-3. Epub 2020 Jun 3. Clin Res Cardiol. 2021. PMID: 32494923
-
Renal Denervation: Is It Ready for Prime Time?Curr Cardiol Rep. 2019 Jul 5;21(8):80. doi: 10.1007/s11886-019-1164-2. Curr Cardiol Rep. 2019. PMID: 31278490 Review.
-
Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients.Medicine (Baltimore). 2019 Jul;98(27):e16116. doi: 10.1097/MD.0000000000016116. Medicine (Baltimore). 2019. PMID: 31277112 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
